These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26909210)

  • 21. Best Reconstructive Techniques: Improving the Final Scar.
    Balaraman B; Geddes ER; Friedman PM
    Dermatol Surg; 2015 Oct; 41 Suppl 10():S265-75. PubMed ID: 26418692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of hypertrophic scars and keloids.
    Berman B; Flores F
    Eur J Dermatol; 1998 Dec; 8(8):591-5. PubMed ID: 9889433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid--two case reports and literature review.
    Iannello S; Milazzo P; Bordonaro F; Belfiore F
    MedGenMed; 2006 Dec; 8(4):60. PubMed ID: 17415337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current methods employed in the prevention and minimization of surgical scars.
    Liu A; Moy RL; Ozog DM
    Dermatol Surg; 2011 Dec; 37(12):1740-6. PubMed ID: 22093099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions.
    Marshall CD; Hu MS; Leavitt T; Barnes LA; Lorenz HP; Longaker MT
    Adv Wound Care (New Rochelle); 2018 Feb; 7(2):29-45. PubMed ID: 29392092
    [No Abstract]   [Full Text] [Related]  

  • 26. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation.
    Lu L; Saulis AS; Liu WR; Roy NK; Chao JD; Ledbetter S; Mustoe TA
    J Am Coll Surg; 2005 Sep; 201(3):391-7. PubMed ID: 16125072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of the efficacy and tolerability of a unique topical scar product vs white petrolatum following shave biopsies.
    Kircik LH
    J Drugs Dermatol; 2013 Jan; 12(1):86-90. PubMed ID: 23377333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
    Seleit I; Bakry OA; Samaka RM; Tawfik AS
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [International clinical recommendations on scar management].
    Ziegler UE
    Zentralbl Chir; 2004 Aug; 129(4):296-306. PubMed ID: 15354252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods.
    Atiyeh BS
    Aesthetic Plast Surg; 2007; 31(5):468-92; discussion 493-4. PubMed ID: 17576505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertrophic scars and keloids in surgery: current concepts.
    Song C
    Ann Plast Surg; 2014 Sep; 73 Suppl 1():S108-18. PubMed ID: 25115371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment outcomes for keloid scar management in the pediatric burn population.
    Patel PA; Bailey JK; Yakuboff KP
    Burns; 2012 Aug; 38(5):767-71. PubMed ID: 22365616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of topical silicone gel elastomers in the treatment of hypertrophic scars, keloid scars, and post-laser exfoliation erythema.
    Chernoff WG; Cramer H; Su-Huang S
    Aesthetic Plast Surg; 2007; 31(5):495-500. PubMed ID: 17700980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modern treatment of keloids].
    Djoković R; Karadaglić Dj
    Srp Arh Celok Lek; 1997; 125(5-6):176-80. PubMed ID: 9265241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of pathological scarring: role of myofibroblasts and current developments.
    Sarrazy V; Billet F; Micallef L; Coulomb B; Desmoulière A
    Wound Repair Regen; 2011 Sep; 19 Suppl 1():s10-5. PubMed ID: 21793960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of keloids and hypertrophic scars.
    Juckett G; Hartman-Adams H
    Am Fam Physician; 2009 Aug; 80(3):253-60. PubMed ID: 19621835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.